Uzma Khan

Uzma Khan is a physician, a public health implementer, researcher, an advocate for TB and for the implementation of integrated, equitable health practices.  Uzma has extensive experience in the evaluation of TB programs; in overseeing, implementing and conducting MDR-TB research; and has provided TB technical assistance to countries in South & Southeast Asia, Africa and the Middle East. She represents IRD as a part of the endTB leadership and is currently a Central Co-I for the endTB clinical trials (www.endTB.org). She previously served as Co-PI of the endTB observational study.  Uzma has provided technical oversight for access to and scale up of hepatitis C services in Pakistan. She is also a member of the regional Green Light Committee (rGLC) for the WHO EMRO region.

Uzma holds a medical degree, as well as a Masters in Epidemiology from the Harvard School of Public Health. Her interests include implementation science, health equity, advocacy and policy.